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X upregulation in mammals increases levels of ex-
pressed X-linked transcripts to compensate for
autosomal biallelic expression. Here, we present
molecular mechanisms that enhance X expression
at transcriptional and posttranscriptional levels.
Active mouse X-linked promoters are enriched in
the initiation form of RNA polymerase II (PolII-S5p)
and in specific histone marks, including histone H4
acetylated at lysine 16 (H4K16ac) and histone variant
H2AZ. The H4K16 acetyltransferase males absent on
the first (MOF), known to mediate the Drosophila X
upregulation, is also enriched on the mammalian X.
Depletion of MOF or male-specific lethal 1 (MSL1) in
mouse ES cells causes a specific decrease in PolII-
S5p and in expression of a subset of X-linked genes.
Analyses of RNA half-life data sets show increased
stability of mammalian X-linked transcripts. Both
ancestral X-linked genes, defined as those con-
served on chicken autosomes, and newly acquired
X-linked genes are upregulated by similar mecha-
nisms but to a different extent, suggesting that
subsets of genes are distinctly regulated depending
on their evolutionary history.
INTRODUCTION
Many organisms have a single X chromosome in males and two
in females. In the heterogametic sex, the X and Y chromosomes
derived from an ordinary pair of autosomes by progressive
degeneration of the Y. Dosage compensation mechanisms
evolved to restore a balanced expression both between the X
and autosomes and between the sexes (Disteche, 2012). Strate-
gies to achieve this compensation vary among species. In
Drosophila, expression of most X-linked genes is increased
2-fold specifically in males (Conrad and Akhtar, 2012). X upre-
gulation also occurs in mammals and in Caenorhabditis elegans
but in both sexes (Gupta et al., 2006; Nguyen and Disteche,D2006). Silencing of one X chromosome by X inactivation in
mammalian females (Lyon, 1961) and repression of both X
chromosomes in C. elegans hermaphrodites (Meyer, 2010)
have been adapted to avoid hyperexpression in the homoga-
metic sex. X upregulation is well supported by expression
analyses of individual genes and by array-based transcriptome
analyses (Adler et al., 1997; Gupta et al., 2006; Nguyen and Dis-
teche, 2006). Although RNA-sequencing analyses did not initially
find evidence of X upregulation in mammals and C. elegans
(Xiong et al., 2010), reanalyses of RNA-seq data accounting for
the skewed gene content of the X chromosome in mammals,
C. elegans, and Drosophila reconfirmed that upregulation of ex-
pressed X-linked genes occurs in all three species (Deng et al.,
2011; Kharchenko et al., 2011; Lin et al., 2011). Interestingly,
the mammalian X chromosome is composed of a mosaic of
two types of genes based on their evolutionary history: ancestral
genes originally present on the autosomes from which the sex
chromosomes derived, and acquired genes recently added to
the X chromosome (Bellott et al., 2010). Whether these genes
are differentially regulated by specific dosage compensation
mechanisms is unknown.
X upregulation could be controlled by DNA-sequence-based
and/or epigenetic mechanisms to control transcription, RNA
stability, and/or translation. In Drosophila, the male-specific
lethal (MSL) complex directs the acetyltransferase males absent
on the first (MOF) to the male X to acetylate histone H4 at lysine
16 (H4K16ac) and enhance transcription (Conrad and Akhtar,
2012). Although increased X expression appears to mainly result
from enhanced transcriptional elongation (Larschan et al., 2011),
a recent study suggests that initiation may also play a major role
(Conrad et al., 2012). In mammals, the existence of epigenetic
components involved in X upregulation is supported by our
previous analyses of human triploid cells (Deng et al., 2009). In
addition, RNA polymerase II phosphorylated at serine 5 (PolII-
S5p), which regulates the transition from preinitiation to early
elongation (Buratowski, 2009; Phatnani and Greenleaf, 2006),
is higher at the 50 end of mouse X-linked versus autosomal genes
(Deng et al., 2011). A recent study confirmed these findings as
well as reported enrichment in other active chromatin marks on
the mouse X chromosome (Yildirim et al., 2011).
To identify molecular mechanisms of X upregulation in mam-
mals, we determined the genome-wide distributions of theevelopmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc. 55
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S5p (phosphorylated at serine 5), and PolII-S2p (phosphorylated
at serine 2), and of histone modifications in mouse cell lines and
tissues. To address the function of the H4K16 acetyltransferase,
MOF occupancy profiles were established and knockdowns of
MOF and MSL1 were done in mouse embryonic stem (ES)
cells. Our results support a conserved role for the MSL com-
plex to enhance transcription initiation and expression of a
subset of X-linked genes. Furthermore, we found that the
half-life of X-linked transcripts is longer relative to autosomal
transcripts. These transcriptional and posttranscriptional mech-
anisms of dosage compensation appear to regulate ancestral
and acquired X-linked genes to various degrees, consistent
with differentially regulated subsets of genes.
RESULTS
PolII-S5p but Not PolII-S2p Is Enriched at the Promoters
of Expressed X-Linked Genes
Chromosome-wide occupancy profiles for PolII-S5p and PolII-
S2p were established to address the role of transcriptional initi-
ation and elongation in mammalian X upregulation. Chromatin
immunoprecipitation combined with arrays (ChIP-chip) analyses
using genome tiling arrays covering mouse chromosomes X and
19 (chr19) were done in undifferentiated female ES cells
PGK12.1. In these cells, both X chromosomes are active (Penny
et al., 1996), resulting in a 1.3–1.4 X:autosome expression ratio
when considering actively expressed genes with R1 reads per
kilobase of exon per million mapped reads (RPKM) measured
by RNA-seq analysis (Figures S1A–S1D available online). Thus,
a substantial level of X upregulation is already evident in these
ES cells prior to differentiation, in agreement with previous
studies (Deng et al., 2011; Lin et al., 2007, 2011). Concordant
with X upregulation metagene analyses demonstrated higher
PolII-S5p occupancy in a promoter-proximal region downstream
of the transcription start site (TSS) of expressed X-linked (387)
versus autosomal (355 chr19-linked) genes (Figure 1A). How-
ever, no X-specific PolII-S5p enrichment was seen at the gene
body and 30 end (Figure 1B).
Average PolII-S5p occupancy within a 1 kb region down-
stream of the TSS and within a 3 kb region upstream of the tran-
scription end site (TES) was quantified for 506 X-linked and 456
chr19-linked genes (>0 RPKM) grouped in 50 expression-ranked
bins. A strong correlation between PolII-S5p occupancy and
gene expression was observed for both X-linked and chr19-
linked genes (Figures 1C and 1E). Importantly, expressed
X-linked promoters (R1 RPKM; Bins 13–50) had significantly
higher (27% increase) average PolII-S5p occupancy compared
to chr19-linked promoters (Figure 1D). In contrast, the gene
body toward the 30 end did not show an X-specific effect except
for a slight increase on highly expressed genes (Bins 40–50)
(Figures 1E and 1F). Higher occupancy by PolII-S5p as well as
by the general form of RNA PolII (30% increase) at expressed
X-linked promoters compared to chr19-linked or to all expressed
autosomal promoters was confirmed in a second undifferenti-
ated female ES cell line CD15 (Figures S1E–S1L). Furthermore,
in undifferentiated male ES cells WD44, X-specific higher
PolII-S5p occupancy was also observed (Figures S1M and
S1N). In contrast, the elongation form of RNA PolII, PolII-S2p,56 Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc.increased toward the 30 end of expressed genes as expected,
but did not show higher occupancy on X-linked genes (Figures
1G–1L).
To directly compare the single active X (Xa) to the inactive X (Xi)
and to a haploid set of autosomes, we used mouse systems with
skewed X inactivation based on crosses between C57BL/6J
(BL6) andMus spretus. In these systems, alleles can be differen-
tiated by frequent SNPs between species, and the Xa compared
to the haploid set of autosomes from the same species (Lingen-
felter et al., 1998; Yang et al., 2010). ChIP combined with
sequencing (ChIP-seq) was done using brain from an adult
female F1 mouse with a BL6 Xa and a spretus Xi. Uniquely map-
ped reads containing informative SNPs were then assigned to
each haploid chromosome set (BL6 or spretus) to establish
allele-specific occupancy profiles. As expected, PolII-S5p occu-
pancy was high on the Xa but very low on the Xi, reflecting gene
silencing (Figures 2A, 2B, and S2A). Interestingly, the few loci
occupied by PolII-S5p on the Xi represent genes known to
escape X inactivation that we and others have previously re-
ported (Figure 2A) (Lopes et al., 2011; Reinius et al., 2010;
Yang et al., 2010). Metagene analyses showed that PolII-S5p
peak levels at promoters of expressed genes on the Xa (R1
RPKM) were 30% higher than those on autosomal genes from
the same species (BL6) (Figures 2B and S2A). Control metagene
analyses of brain genomic DNA sequencing data (input) showed
similar SNP-read counts for the BL6-Xa, spretus-Xi, and BL6-A,
indicating absence of sequencing bias (Figure S2C). Thus, the
ChIP-seq results substantiate those obtained by ChIP-chip
despite apparent differences in the shape of PolII-S5p peaks,
which are probably due to differences between the two method-
ologies (Figures 1A and 2B). An additional analysis in which
genes with significant PolII-S5p peaks (false discovery rate
[FDR]% 1 3 105) within a 1 kb region up- and downstream of
the TSS were selected regardless of their expression levels,
confirmed the Xa-specific enhancement in PolII-S5p occupancy
(Figure S2B). A noticeable shift in distribution profiles further veri-
fied a higher percentage of expressed Xa-linked genes with high
PolII-S5p promoter occupancy compared to autosomal genes
from the same species haploid set (Figure 2C). Medians of
PolII-S5p promoter occupancy were 19%, 8%, and 26% higher,
respectively, for genes grouped by low-, medium-, and high-
expression on the Xa compared to the haploid autosomal set
(p = 0.92, 0.69, and 0.0004, respectively, Wilcoxon test; Fig-
ure 2D). An independent allele-specific ChIP-seq analysis per-
formed on mouse fibroblasts (Patski cell line derived from
embryonic kidney) that have the opposite X inactivation pattern
from the brain sample, i.e., a spretus Xa and a BL6 Xi confirmed
high PolII-S5p levels on the Xa (Figure S2D).
Taken together, our ChIP-chip and ChIP-seq experiments
show enhanced PolII-S5p but not PolII-S2p at the promoter-
proximal region of expressed X-linked genes in mouse ES cells,
fibroblasts, and brain. Thus, transcription initiation is apparently
enhanced to contribute to X upregulation inmammalian cells and
tissues.
Specific Epigenetic Modifications Are Enriched at the
Promoters of Expressed X-Linked Genes
Genome-wide profiles of histone modifications were initially
established by ChIP-chip using promoter arrays for mouse
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Figure 1. PolII-S5p but Not PolII-S2p Occupancy Is Enhanced at Expressed X-Linked Genes in Female ES Cells
ChIP-chip analyses using genome tiling arrays to survey X-linked (X) and autosomal (A) genes in undifferentiated female ES cells PGK12.1.
(A andB)Metagene analyses of 355 X-linked and 387 chr19-linked expressed genes (R1RPKM). Average PolII-S5p occupancy (log2 ChIP/input) was plotted 3 kb
up- and downstream of the TSS (transcriptional start site) (A) and TES (transcriptional end site) (B) in a 500 bp sliding window (100 bp intervals).
(C) Average binding scores of PolII-S5p in a 1 kb region downstream of the TSS plotted for 50 expression-ranked bins, each containing ten X-linked and nine
chr19-linked genes. A total of 506 X-linked and 456 chr19-linked genes (>0 RPKM) were examined. Regression values (R2) and trend lines are shown.
(D) Box plots of PolII-S5p occupancy at the promoter of expressed X-linked and chr19-linked genes (R1 RPKM). P values from Wilcoxon test are shown.
(E) Average binding scores of PolII-S5p in a 3 kb region upstream of the TES (30 gene body) plotted for 50 expression-ranked bins. Same analysis as described
in (C).
(F) Box plots of PolII-S5p occupancy at the 30 gene body of expressed X-linked and chr19-linked genes (R1 RPKM). Same analysis as described in (D).
(G–L) Occupancy of PolII-S2p at the 50 or 30 end of X-linked and chr19-linked genes. Same analyses as described in (A)–(F).
See also Figure S1.
Developmental Cell
X-Enhanced Transcript Initiation and RNA Half-Life
Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc. 57
A B
C D E
Figure 2. Higher PolII-S5p Occupancy at Expressed X-Linked versus Autosomal Genes by Allele-Specific ChIP-Seq Analyses in Brain
Allele-specific ChIP-seq in brain of an F1 mouse with the BL6 X chromosome active (Xa), and the spretus X inactive (Xi).
(A) Chromosome-wide allele-specific PolII-S5p occupancy profiles of the Xa and Xi are shown as SNP read counts in 10 kb windows. Read counts for genes that
escape X inactivation (Ddx3x, Kdm6a, 6720401G13Rik, Eif2s3x, Xist, Kdm5c, Mid1) are indicated (pink dots).
(B) Metagene analysis of PolII-S5p occupancy at the 50 end of expressed genes (R1 RPKM) on the Xa (Xa_BL6) (398 X-linked genes) and on the haploid set of
autosomes (A_BL6) (11,335 autosomal genes). SNP-read counts plotted 3 kb up- and downstream of the TSS in 100 bp windows.
(C) Percentage of expressed genes with PolII-S5p promoter occupancy is higher on the Xa (Xa_BL6) than on autosomal genes from the same haploid set (A_BL6)
(p = 0.007, Kolmogorov–Smirnov [KS] test). Normalized promoter PolII-S5p density was calculated by averaging SNP-read counts in six 100 bp windows around
the TSS (peak region) for expressed genes, and normalizing by the median value of genomic DNA-SNP-read counts 3 kb up- and downstream of the TSS.
(D) Box plots of normalized allele-specific promoter PolII-S5p density on expressed genes on the Xa compared to those on the haploid set of autosomes in each of
the expression groups (low-, medium-, and high-expression). P values from Wilcoxon test are shown.
(E) Metagene analysis of PolII-S5p allele-specific occupancy at the 50 end of expressed ancestral X-linked genes (282 genes) and acquired X-linked genes
(155 genes), compared to ancestral autosomal genes (421 genes).
See also Figure S2.
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promoter-associated active histone modifications examined
(H3K4me3, H3ac, and H4K16ac) only H4K16ac showed a
prominent enrichment on expressed X-linked versus autosomal
genes (41% average increase in peak values; Figure 3A).
H4K16ac levels were well correlated with expression, based on
average promoter-binding scores within a 1 kb region down-
stream of the TSS for 506 X-linked and 12,755 autosomal genes
(>0 RPKM) sorted in 50 expression bins. Importantly, binding
scores were on average 2-fold higher for expressed X-linked
genes than for autosomal genes (Figures 3B and 3C). H4K16ac
enrichment was also well correlated with PolII-S5p (Figure 3G),
in agreement with the role of H4K16ac in opening chromatin
and activating transcription (Akhtar and Becker, 2000). In con-
trast, H3K4me3 and H3ac showed little or no X-specific enrich-
ment (Figures S3C and S3D). A control antibody for unmodified
pan-H3 demonstrated little difference in nucleosome distribution
between X and autosomes (Figure S3A), and when H3 profiles
were used for normalization of histone modification profiles no
appreciable changes were observed (compare Figures 3A and
3D to S3B and S4E).
The X-specific enrichment in H4K16ac at the 50 end of mouse
genes suggests that this histone modification may have a58 Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc.conserved role in flies and mammals. However, in Drosophila
X-specific enrichment in H4K16ac predominates at the gene
body toward the 30 end, which would facilitate transcription elon-
gation (Gelbart et al., 2009). We did not observe this in mouse
cells; rather, the X-specific H4K16ac enrichment was limited to
the promoter-proximal region, and did not extend to the 30 end
of the gene body, as shown by metagene analyses based on
tiling arrays covering mouse chromosomes X and 19. However,
H4K16ac levels were higher in genic than intergenic regions and
did increase toward the 30 end of both X-linked and autosomal
genes (Figures S3E–S3H). Metagene profiles for H3K36me3,
another histone modification involved in active elongation, also
showed no X-specific enrichment at the gene body (Figures
S3I–S3L). These observations along with high PolII-S5p, but
not PolII-S2p, on X-linked genes suggest that transcription initi-
ation rather than elongation may play a major role in mammalian
X upregulation.
We also established distribution profiles for H2AZ, a histone
variant implicated in different aspects of gene regulation. The
acetylated form of H2AZ (H2AZac) is associated with active
genes, and the nonacetylated form with repressed genes
(Valdes-Mora et al., 2012). Metagene profiles showed that pan-
H2AZ levels were higher within two regions at the 50 end of
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Figure 3. Higher Levels of H4K16ac and H2AZ at the 50 End of Expressed X-Linked versus Autosomal Genes in Female ES Cells
ChIP-chip analyses using promoter arrays in undifferentiated female ES cells PGK12.1. Regression values (R2) are shown where appropriate.
(A) Metagene analysis of H4K16ac at the promoter-proximal region of expressed X-linked (X) and autosomal (A) genes. Average enrichment (log2 ChIP/input) was
plotted 3 kb up- and downstream of the TSS for 387 X-linked and 9800 autosomal expressed genes (R1 RPKM).
(B) Average binding scores of H4K16ac in a 1kb region downstream of the TSS plotted for 50 expression-ranked bins, each containing ten X-linked and 255
autosomal genes. A total of 506 X-linked and 12,755 autosomal genes (>0 RPKM) were examined.
(C) Box plots of promoter-binding scores of H4K16ac on expressed X-linked and autosomal genes (R1 RPKM). P value from Wilcoxon test is shown.
(D) Metagene analysis of H2AZ at the 50 end of expressed X-linked and autosomal genes. Same analysis as in (A).
(E and F) Average binding scores of H2AZ in a 0.5–1.5 kb region upstream of the TSS (E) and a 1 kb region downstream of the TSS (F). Same analysis as in (B).
(G–I) PolII-S5p promoter-proximal occupancy at expressed X-linked genes is well correlated with H4K16ac promoter enrichment (G) but not with H2AZ (H and I).
See also Figures S3 and S4.
Developmental Cell
X-Enhanced Transcript Initiation and RNA Half-LifeX-linked versus autosomal genes, a promoter-distal region
located 0.5–1.5 kb upstream of the TSS (20% increase in peak
values) and a promoter-proximal region at 0–1 kb downstream
of the TSS (2-fold increase in peak values) (Figure 3D). No
X-specific H2AZ enrichment was detected at the gene body
toward the 30 end (Figures S4A and S4B). Similar results were
obtained for H2AZac, suggesting that profiles obtained for
pan-H2AZ represent the acetylated form associated with gene
activation (Figures S4C and S4D). The H2AZ enrichment either
upstream or downstream of the TSS was not correlated with
gene expression levels (Figures 3E and 3F). Similarly, PolII-S5p
occupancy was not correlated with H2AZ enrichment at ex-
pressed X-linked genes (Figures 3H and 3I), in contrast to what
we observed for H4K16ac (Figure 3G). The distinct metageneDprofiles for H4K16ac and H2AZ suggest that these marks prob-
ably play separate roles in regulation of transcription initiation
involved in X upregulation.
We next determined whether MOF, the enzyme that specifi-
cally acetylates H4K16, is involved inmammalian X upregulation.
MOF occupancy was specifically enhanced at the promoter-
proximal region of expressed X-linked versus autosomal genes
in mouse ES cells (Figures 4A, S5A, and S5B). MOF promoter-
binding scores were on average 2-fold higher for expressed
X-linked versus autosomal genes and were correlated with
expression (Figures 4B and 4C). As expected, MOF occupancy
was also well correlated with H4K16ac enrichment and with
PolII-S5p occupancy at expressed X-linked promoters (Figures
4D and 4E). This pattern initially determined in undifferentiatedevelopmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc. 59
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Figure 4. MOF Is Enriched at the 50 End of X-Linked Genes, and Knockdown Reduces Accumulation of H4K16ac and PolII-S5p Occupancy
ChIP-chip analyses using promoter arrays in undifferentiated female ES cells PGK12.1. Regression values (R2) are shown where appropriate.
(A) Metagene analysis of MOF occupancy at the promoter-proximal region of expressed X-linked (X) and autosomal (A) genes. Same analysis as in Figure 3A.
(B) Average binding scores of MOF in a 1 kb region downstream of the TSS plotted for 50 expression-ranked bins. Same analysis as in Figure 3B.
(C) Box plots of promoter-binding scores of MOF on expressed X-linked and autosomal genes (R1 RPKM). P value from Wilcoxon test is shown.
(D and E) Correlations between MOF promoter-proximal occupancy at expressed X-linked genes with H4K16ac (D) and PolII-S5p promoter enrichment (E).
(F–H) qRT-PCR (F), western blots (G), and immunostaining (H) in control (scramble siRNA) andMOFRNAi-treated cells.Mof expression set to 1 in control cells and
b-actin used for normalization. Error bars represent SD. b-Actin and H3 antibodies serve as controls for the western blot. DNA stained by Hoechst 33342 (blue).
(legend continued on next page)
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female ES cell line CD15 (data not shown), and in male ES cells
(Figure S5C). These findings suggest that MOF and H4K16ac
help recruit PolII-S5p for transcription initiation at X-linked
promoters.
Both Ancestral and Acquired Genes on the Mouse X
Chromosome Have Enhanced PolII-S5p, H4K16ac,
H2AZ, and MOF
We sorted our data to examine ancestral and acquired X-linked
genes separately as they may be differentially regulated. Ances-
tral mouse X-linked genes represent genes originally present on
the autosomes fromwhich the current mouse sex chromosomes
derived; they can be identified by comparison to the chicken
genome in which orthologs are located within two main blocks
of conservation on autosomes 1 and 4 (Kohn et al., 2004).
Acquiredmouse X-linked genes are those added since the diver-
gence of the mouse sex chromosomes from an ancestral pair of
autosomes (Bellott et al., 2010). The acquired category includes
many of the multicopy X-linked genes that have testis-specific
expression; these genes being silent in mouse ES cells were
excluded from our metagene analyses. We also included a
control subset of ancestral mouse autosomal genes (orthologs
of chicken Z-linked genes).
Significantly higher PolII-S5p and MOF occupancy as well as
H4K16acandH2AZenrichmentwere observedonboth ancestral
(240 genes) and acquired X-linked genes (147 genes) compared
to ancestral autosomal genes (331 genes) (Figures S1O, S4F,
S4G, and S5D). This is concordant with X:A mean expression
ratios of 1.57 and 1.94 for ancestral and acquired genes, respec-
tively, in undifferentiated female ES cells PGK12.1. Acquired
X-linked genes appeared to have the highest occupancy/enrich-
ment in active marks, but the promoter-binding scores for each
group were not significantly different from each other (Figures
S1P, S4H–S4J, and S5E). Higher PolII-S5p promoter occupancy
in both groups of X-linked genes was confirmed in vivo based on
allele-specific ChIP-seq analyses of mouse brain (Figure 2E). In
contrast, no or only a slight enrichment was observed for
H3K4me3 or H3ac in either group of X-linked genes compared
to ancestral autosomal genes (data not shown). Similar results
were obtained when all expressed autosomal genes were used
for comparison, rather than the subset of orthologs of chicken
Z-linked genes (data not shown). We conclude that, regardless
of their evolutionary origin, expressed mouse X-linked genes
display enhanced levels of PolII-S5p, MOF, H4K16ac, and
H2AZ associated with X upregulation.
MOF Knockdown Decreases H4K16ac and PolII-S5p
Occupancy and X-Linked Gene Expression in ES Cells
To address the functional role of MOF in X upregulation, mouse
cells were transfected with a mixture of three small interfering
RNA duplexes, each of which targets a different region of Mof
mRNA. Quantitative RT-PCR (qRT-PCR) showed a 70%–80%(I) Average PolII-S5p promoter binding scores within 1 kb downstream of the T
categories (see Experimental Procedures), compared between control undiff
(MOF RNAi).
(J) Percentages of PolII-S5p promoter binding decrease afterMOF knockdown for
See also Figure S5.
Ddecrease in Mof mRNA, which led to a dramatic decrease in
MOF protein detected by western blots and immunostaining
(Figures 4F–4H). As expected, the levels of H4K16ac were also
greatly reduced (Figures 4G and 4H). Although cells grew more
slowly after MOF knockdown compared to control cultures as
previously reported (Gupta et al., 2008; Thomas et al., 2008),
no obvious cell death or abnormal cell morphology were
observed (Figure 4H). Interestingly, MOF knockdown in undiffer-
entiated female ES cells PGK12.1 caused a significant reduction
not only in H4K16ac but also in PolII-S5p occupancy at the 50 end
of expressed genes, with a more severe effect on medium-ex-
pressed X-linked genes (Figures 4I, 4J, and S6A–S6C). These
findings support a role for MOF and H4K16ac in transcription
initiation by mediating PolII-S5p recruitment. MOF knockdown
did not affect H2AZac enrichment, corroborating the idea that
H2AZ acts independent of H4K16ac and MOF (data not shown).
MOF knockdown in female ES cells caused a greater drop in
expression of X-linked genes compared to autosomal genes,
as measured by expression array analyses. Levels of genes in
all expression categories (low, medium, and high) decreased
(Figure 5A). However, the strongest effect was observed on
medium-expressed X-linked genes whose average expression
level decreased by 12% (Figure 5B), in agreement with the
significant decrease in H4K16ac (35%) and in PolII-S5p (26%)
at these genes (Figures S6C and 4J). Overall, a subset of 70
X-linked genes was apparently MOF-sensitive in female ES
cells PGK12.1 (Table S1). The X-specific effect persisted when
comparing X-linked genes to genes from a single autosome
(chr19) (Figure S6D). Furthermore, a significantly greater propor-
tion of X-linked genes in the medium expression category were
downregulated compared to other expression categories, or to
autosomal genes in any expression category (>1.2-fold down;
p < 0.05, Student’s t test; Figure 5B; Table S1). Interestingly,
a significantly greater proportion of downregulated X-linked
genes (50 out of 70 genes; p = 2 3 106, c2 test; Figure S6E)
were from the ancestral group compared to the acquired group
(Figure S6E; Table S1). No such trend was detected for upregu-
lated ancestral (six genes) or acquired (five genes) X-linked
genes.
These results were confirmed by qRT-PCR for three medium-
expressed and five high-expressed X-linked genes after MOF
knockdown in two undifferentiated female ES cell lines
(PGK12.1 and E8) (Figures 5C and S6F). Similar results were
also obtained for each MOF siRNA duplex separately, ruling
out off-target effects (Figure S6G). MOF knockdown did not
induce aberrant female ES cell differentiation, which would
trigger X-inactivation and confound results due to silencing of
one allele. Indeed, expression of ten stem-cell-specific genes
showed no obvious changes (Figure S6H). In addition, Xist
RNA FISH confirmed the absence of an inactive X after knock-
down (Figure S6I). MOF knockdown in two undifferentiated
male ES cell lines (E14 and WD44) also caused a specific
reduction in levels of medium-expressed X-linked genes (FiguresSS for 626 X-linked and 15,944 autosomal genes grouped in four expression
erentiated female ES cells PGK12.1 (control RNAi) and MOF knockdown
expressed X-linked (X) and autosomal (A) genes in three expression categories.
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Figure 5. MOF Knockdown Specifically Decreases Expression of X-Linked Genes in Female and Male ES Cells
(A) Box plots of expression fold changes for X-linked (X) and autosomal (A) genes grouped in four expression categories (see Experimental Procedures) after MOF
knockdown in undifferentiated female ES cells PGK12.1. X-linked genes with medium expression levels show the most significant decrease compared to
autosomal genes (p < 2 3 1016, one-way ANOVA), or to X-linked genes in other categories (p < 6 3 1010).
(B) Percentages of X-linked (X) and autosomal (A) genes in each expression category with a >1.2-fold expression change (p < 0.05, two-tail paired t test) afterMOF
knockdown in undifferentiated female ES cells PGK12.1. Genes with decreased expression (down) or with increased expression (up) are indicated.
(C) Quantitative RT-PCR analyses of the effects of MOF knockdown on expression of three medium-expressed (Car5b, Rpgr, and Cetn2) and five highly ex-
pressed (Hprt1, Pgk1, Eif2s3x, Cdk16, and Kdm5c) X-linked genes in male (WD44 and E14) and female (PGK12.1 and E8) ES cells. The 18S housekeeping gene
was used for normalization. Error bars represent SD.
(D) Box plots of expression fold changes for X-linked (X) and autosomal (A) genes grouped in four expression categories after MOF knockdown in undifferentiated
male ES cells E14. X-linked genes with medium expression levels show the most significant decrease compared to autosomal genes (p < 8 3 105, one-way
ANOVA), or to X-linked genes in other categories (p < 0.0004).
(E) Percentages of X-linked (X) and autosomal (A) genes in each expression category with a >1.2-fold expression change (p < 0.05, two-tail paired t test) after MOF
knockdown in undifferentiated male ES cells E14. Same analysis as in Figure 5B.
(F) Expression of X-linked genes sorted in 18 expression-ranked bins (each containing 50 X-linked genes) after MOF knockdown in undifferentiated male ES cells
E14 (one active X) and female ES cells PGK12.1 (two active Xs). Average log2 fold change between knockdown and control is shown. Error bars represent SD.
See also Figure S6 and Table S1.
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than in female ES cells (Figure 5F), which could be due either
to lower sensitivity of microarray analysis for the detection of
expression changes in cells with a single active X chromosome,
or to sex-specific differences.
We next examined components of the two knownMOF protein
complexes, male-specific lethal1 (MSL1) and nonspecific lethal1
(NSL1) (Mendjan et al., 2006; Prestel et al., 2010; Raja et al.,
2010). Knockdown of MSL1, but not NSL1, in undifferentiated
female ES cells PGK12.1specifically caused a decrease in ex-
pression levels of X-linked genes (Figures S6M and S6O).
Medium-expressed X-linked genes again showed the greatest
effect, similar to MOF knockdown. Cells cotransfected with
both MOF and MSL1 siRNAs had similar expression changes
to MSL1 knockdown alone, indicating that these components
probably operate within the same complex but are not additive
(Figure S6N). Furthermore, a larger subset of medium-expressed
X-linked genes (32% versus 3%–8% for genes in other quad-62 Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc.rants) was co-downregulated, whereas autosomal genes did
not show such an effect (Figures 6A and 6B; Table S2). In
contrast, no prominent X-specific co-downregulation was
observed between MOF and NSL1 knockdown (Figures 6C
and 6D). We conclude that key components of the MSL but
not NSL complex play a role in upregulation of mammalian X-
linked genes in ES cells.
Longer RNA Half-Life of X-Linked versus Autosomal
Genes Contributes to X Upregulation
To determine whether posttranscriptional mechanisms were in-
volved in mammalian X upregulation, we reanalyzed data from
two published studies of genome-wide RNA half-life profiles
(Clark et al., 2012; Tani et al., 2012). Distributions of half-life
in human HeLa cells and mouse Neuro-2A cells showed a sig-
nificantly higher percentage of X-linked transcripts with long
half-life compared to autosomal transcripts (Figures 7A and
7C). Box plots confirmed an overall longer half-life for X-linked
A B
C D
Figure 6. A High Percentage of Medium-
Expressed X-Linked Genes Is Specifically
Co-Downregulated after MOF or MSL1—
but Not NSL1—Knockdown
(A and B) Comparison of expression fold changes
(log2) between MOF and MSL1 knockdown for
X-linked (red) and autosomal (gray) genes in the
medium-expression (A) and high-expression (B)
categories (representing a total of 227 X-linked and
5,316 autosomal genes in each category). The
percentages of X-linked and autosomal genes (in
parentheses) with >10% change in expression
(±0.1 in log2) in both knockdowns are indicated in
each quadrant.
(C and D) Comparison of expression fold changes
between MOF and NSL1 knockdown. Similar
analysis as in (A) and (B).
See also Table S2.
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vidual autosomes (Figures 7B, 7D, S7A, and S7B). There was
no significant difference in the half-life of X-linked genes grouped
as either ancestral or acquired (using the criteria described
above) (Figures S7C–S7F). Additional reanalyses of published
microarray data (Sharova et al., 2009) showed that X:autosome
expression ratios increased by 10%–20% after inhibition of tran-
scription in undifferentiated and differentiated male mouse ES
cells, indicating greater stability of X-linked transcripts regardless
of their evolutionary origin (Figures 7E and 7F). Interestingly, the
18MOF-sensitive X-linked genes (representing part of the subset
of 70MOF-sensitive genes; Table S1) for which therewas half-life
information in the Neuro-2A data set, had a shorter median half-
life (4.2 hr), compared to all X-linked (5.8 hr) or to all autosomal
transcripts (5.0 hr). In addition, although 39 of the 70MOF-sensi-
tiveX-linkedgenes showedenhanced transcript abundanceafter
transcription inhibition in male ES cells, 30 others failed to show
any change or even showed a decrease in transcript abundance,
suggesting that subsets of X-linked genes may be subject to
different types or levels of dosage regulation. Overall, these
findings indicate increased stability of X-linked transcripts (or
decreased stability of autosomal transcripts), which would con-
tribute to balanced expression between X and autosomes.
DISCUSSION
Our findings of enhanced chromatin modifications associated
with transcription initiation on the mouse X chromosome appearDevelopmental Cell 25, 5distinct from the proposed mechanism of
X upregulation in Drosophila in which
enhanced elongation plays a major role
(Larschan et al., 2011). However, a recent
study reports enhanced recruitment of
PolII to X-linked promoters in male
Drosophila (Conrad et al., 2012), which is
similar to what we observed on mouse
X-linked promoters. In their study, Conrad
et al. (2012) demonstrate that knockdown
of MSL2, the key component of the MSL
complex that assembles on the male X,affects the recruitment of PolII to X-linked promoters but not to
the gene body, suggesting a major role for enhanced transcrip-
tion initiation. Acetylation of H4K16 mediated by MOF is known
to open chromatin structure and activate transcription (Akhtar
and Becker, 2000), as well as to enhance the release of paused
PolII from promoters (Kapoor-Vazirani et al., 2011; Zippo et al.,
2009). Our findings of a good correlation between PolII-S5p
occupancy and gene expression support a role in facilitating
transcription rather than representing stalling of the RNA poly-
merase. Enrichment in H4K16ac andMOF was observed specif-
ically at the promoter-proximal region of mammalian X-linked
genes, in a region known to be important for efficient transcrip-
tion initiation and pause release (Appanah et al., 2007; Buratow-
ski, 2009). This may facilitate transcription initiation/reinitiation
and PolII pause release, and thus play a conserved role in X up-
regulation. In male Drosophila, H4K16ac is dominantly enriched
on the body of X-linked genes, suggesting amajor role in elonga-
tion, but it is also observed at the 50 end of autosomal and
X-linked genes in both sexes (Feller et al., 2012; Kind et al.,
2008; Prestel et al., 2010; Raja et al., 2010). An important factor
that may contribute to differences between flies andmammals is
gene length, which is relatively constant in Drosophila but highly
variable in mammals (50 bp to 2 Mb). Transcription levels would
be affected by gene length if the elongation rate is a rate-deter-
mining step (Conrad and Akhtar, 2012). Given that the process of
transcription elongation inmammals is a fast turnover, enhanced
initiation rather than elongation would have the advantage of
increasing transcript levels despite variable length.5–68, April 15, 2013 ª2013 Elsevier Inc. 63
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E F
Figure 7. Longer Half-Life of X-Linked
Transcripts Compared to Autosomal Tran-
scripts in Mammalian Cells
(A) Distribution of half-life for 327 X-linked and
10,252 autosomal transcripts in human HeLa
cells shows a higher percentage of X-linked tran-
scripts with long half-life (p = 6 3 1013, KS test).
Published BRIC-seq data were reanalyzed (Tani
et al., 2012). Only expressed genes with >1 RPKM
were included.
(B) Box plots of half-life for human X-linked and
autosomal transcripts. P values by Wilcoxon test
are shown.
(C) Distribution of half-life for 266 X-linked and
9,131 autosomal transcripts in mouse Neuro-2A
cells shows a higher percentage of X-linked
transcripts with long half-life (p = 0.02, KS test).
Published array data were reanalyzed (Clark et al.,
2012).
(D) Box plots of half-life for mouse X-linked and
autosomal transcripts. P values by Wilcoxon test
are shown.
(E) X:autosome expression ratios after inhibition of
transcription in male mouse ES cells. Reanalysis
based on published microarray data on undiffer-
entiated (MC1, MC2) and differentiated (by LIF
withdrawal [MC1-L] or retinoic acid treatment
[MC1-R]) mouse ES cells harvested at 0, 1, 2, 4,
and 8 hr after addition of actinomycin D (Sharova
et al., 2009).
(F) Same analysis as in (E) for X-linked genes
grouped as either ancestral or acquired. The
transcript abundance at 0 hr was set to 1 and used
to calculate the relative transcript abundance of
22,166 autosomal (A) genes and of 865 X-linked (X)
genes grouped as either ancestral (400 genes) or
acquired (465 genes). Means ± SD are shown
based on two microarray data sets (MC1-L and
MC1-R).
See also Figure S7.
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S5p at the 50 end of expressed X-linked genes compared to
autosomal genes, with a higher level in brain than in fibroblasts,
probably reflecting high X expression in brain (Nguyen and Dis-
teche, 2006). Our results are comparable to those reported in
a recent allele-specific ChIP-seq study in which cloned mouse
fibroblasts showed a similar Xa-specific enrichment in PolII-
S5p (31%) (Yildirim et al., 2011). However, although we did not
observe an X-specific enrichment in PolII-S2p and H3K36me3
by ChIP-chip inmouse ES cells, this study reported some enrich-
ment in PolII-S2p (20% increase) and H3K36me3 (9%) along the
body of X-linked genes (Yildirim et al., 2011). These differences
may be related to the use of different cell types/tissues and/or
methodologies. For example, a high turnover of PolII in ES cells
could explain the absence of detectable enrichment at the
gene body in our study. Our results on H3K36me3 are similar
to those obtained in Drosophila, where no X-specific enrichment
has been detected, even though H3K36me3 may facilitate MSL64 Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc.binding to the male X (Larschan et al.,
2007). We found that H2AZ was in-
creased at the 50 end of X-linked genes
but that it probably plays a separate role from H4K16ac. H2AZ
often associates with chromatin remodelers (e.g., ATP-depen-
dent ISWI) (Goldman et al., 2010). Studies in Drosophila suggest
that H4K16ac directly counteracts the chromatin compaction
mediated by ISWI (Corona et al., 2002). In mammals, H2AZ could
potentially constrain X upregulation by counteracting H4K16ac
to fine-tune gene expression levels and achieve doubling.
In mouse ES cells, MOF and MSL1 knockdown, but not NSL1
knockdown, significantly diminished the expression of medium-
expressed X-linked genes via lower levels of PolII-S5p. The MSL
complex may facilitate mammalian X upregulation in early devel-
opment, which is supported by high MOF and MSL expression
specifically in early mouse embryos (Zeng et al., 2004). Addi-
tional studies will be necessary to determine whether MOF is still
important for X upregulation later in development and in adult
tissues. Our studies also suggest that MOF may regulate only
certain subsets of X-linked genes. We speculate that specific
subsets such as those with medium expression could be more
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genes to changes in key dosage regulators such asMOF or other
components of the dosage compensation machinery in early
development. This is consistent with our previous study of
human triploid cells in which expression of a subset of dosage
sensitive X-linked genes is apparently adjusted to achieve
balance with the autosomes (Deng et al., 2009). Interestingly,
expression levels of the mouse X-linked orthologs to these
human dosage-sensitive genes were significantly decreased
(by 9%) after MOF knockdown, suggesting that this same sub-
set of genes may be more sensitive to changes in MOF and
H4K16ac. The existence of a subset of dosage sensitive genes
on the mammalian X chromosome is supported by analyses
of X-linked and autosomal genes involved in large protein
complexes that require maintenance of stoichiometry (Pessia
et al., 2012). Our reanalysis of published data shows that in
Drosophila downregulation of gene expression after knockdown
of components of the MSL complex including MOF is also most
pronounced for medium-expressed genes (data not shown)
(Hamada et al., 2005; Kind et al., 2008). Yet, the extent of gene
expression changes observed after MOF knockdown in mouse
ES cells is less than that reported in Drosophila, perhaps partly
due to incomplete knockdown in mouse cells. Unfortunately,
the lethality of MOF null mutations (Gupta et al., 2008; Thomas
et al., 2008) and the dramatic changes in chromatin structure
and expression of thousands of genes (including the core ES
essential genes) observed in inducible MOF knockout ES cells
(Li et al., 2012), preclude the study of X-specific effects resulting
from complete loss of MOF.
In addition to transcriptional regulation, posttranscriptional
regulatory mechanisms such as RNA transportation and stability
may also be involved in X upregulation (Disteche, 2012).
Nonsense-mediated mRNA decay (NMD) has been previously
implicated in mammalian X upregulation by demonstrating that
inhibition of the NMD pathway decreases the X:A expression
ratio in human cells (Yin et al., 2009). Our results, based on rean-
alyses of published measurements of RNA amounts following
inhibition of transcription (Clark et al., 2012; Sharova et al.,
2009; Tani et al., 2012), are in agreement with a longer half-life
for X-linked genes compared to autosomal genes. Although
the half-life data we reanalyzed were obtained in transformed
human and mouse cell lines, we also confirmed greater stability
of X-linked transcripts in mouse ES cells. Thus, X upregulation in
mammals apparently results from a combination of mechanisms
that involve transcriptional and posttranscriptional regulation.
Transcriptional regulation may involve targeting of factors to
the active X and potential sequestration in a special nuclear
compartment as suggested in Drosophila (Conrad and Akhtar,
2012), whereas regulation of RNA stability would suggest
transcript sequence differences at the 50 and 30 end UTR. In
Drosophila, doubling of gene expression on the male X chromo-
some apparently involves both a basal buffering mechanism in
response to aneuploidy and a feed-forward mechanism targeted
to the X via the MSL complex (Zhang et al., 2010). Reverse
dosage effects on autosomes have also been proposed (Birchler
et al., 2011). In mammals, enhanced initiation of transcription via
MOF and H4K16ac may be a conserved feed-forward upregula-
tion mechanism, with increased RNA stability further contrib-
uting to X upregulation.DAncestral X-linked genes have persisted on the mammalian X
chromosome even though the sex chromosomes have diverged
for more than 130 million years (Lahn and Page, 1999). During
that time hundreds of genes have also been acquired (Bellott
et al., 2010). For ancestral X-linked genes, dosage compensa-
tion may have immediately followed loss of the Y-linked copy,
whereas for acquired X-linked genes dosage regulation may
result in part from position effects due to relocation. We found
that ancestral X-linked genes may be more sensitive to changes
in MOF compared to newly acquired X-linked genes, suggesting
that ancestral X-linked genes are the primary targets of this
dosage compensation machinery. Two recent studies based
on expression analyses using RNA-seq have compared expres-
sion of ancestral X-linked genes to their orthologs in chicken and
concluded that there is little or no upregulation of ancestral
X-linked genes in eutherian mammals (Julien et al., 2012; Lin
et al., 2012). Our conclusions differ as we did find higher levels
of PolII-S5p, H4K16ac, and H2AZ, and a longer half-life for
both ancestral and acquired expressed X-linked genes com-
pared to autosomal genes. A potential problem with the RNA-
seq studies is the inclusion of nonexpressed genes, which
are abundant on the mammalian X chromosome and lower
median expression values (Deng et al., 2011). In addition, the
RNA-seq data normalization needed to compare expression
levels of hundreds of genes across distant species is compli-
cated because the chicken genome is not well annotated
compared to the mouse or human genomes. A major difference
with our study is that we examined expressed X-linked genes, an
appropriate gene set when considering mechanisms of dosage
compensation. It should be noted that in Drosophila, the X
upregulation machinery preferentially assembles at expressed
genes (Alekseyenko et al., 2006; Gilfillan et al., 2006), and that
enhanced PolII occupancy at the 50 end of genes is observed
only on expressed genes, similar to what we report (Conrad
et al., 2012).
In conclusion, mammalian X upregulation is apparently medi-
ated by both transcriptional and posttranscriptional mecha-
nisms. Transcriptional effects appear to predominantly operate
by epigenetic modifications at the 50 end of X-linked genes.
Posttranscriptional effects on RNA stability may result from
epigenetic and/or sequence-specific characteristics. Our results
further suggest that subsets of X-linked genes may be differen-
tially regulated by these mechanisms and that the timing of
acquisition of genes on the X chromosome may play an impor-
tant role in regulatory mechanisms.
EXPERIMENTAL PROCEDURES
ChIP-Chip Analysis
ChIP-chip was performed using fixed chromatin from mouse cell lines and
brain as previously described (Yang et al., 2010). Details about the cell lines
and brain sample and about antibodies used for ChIP are described in
Supplemental Experimental Procedures. All animal procedures were per-
formed under the ethical guidelines of the University of Washington Institu-
tional Animal Care and Use Committee. After chromatin labeling hybridization
was done using two types of arrays: NimbleGen mouse 2.1 M tiling arrays (set
10; mm 8 design) that cover the entire X chromosome, half of chr18, and the
entire chr19, and (2) NimbleGen 2.1 M mouse promoter tiling arrays (mm 8
and mm 9 design: tiling regions covering 8 kb upstream3 kb downstream
of 24,000 and 24,507 promoters, respectively). GFF ratios (log2 ChIP/
input) and peak files were generated using Nimblescan software with defaultevelopmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc. 65
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lated using a 500 bp sliding window (100 bp interval) by metagene analysis
(Mito et al., 2005). Only unique RefSeq genes including 626 X-linked and
15,944 autosomal genes were analyzed. For the genome tiling array data,
456 chr19-linked and 506 X-linked genes (>0 RPKM) were grouped into
50 expression bins based on expression levels from RNA-seq. For the
promoter tiling array data, 12,755 (12,004 for mm 9) autosomal genes and
506 (478 for mm 9) X-linked genes (>0 RPKM) were grouped into 50 expres-
sion bins.
ChIP-Seq Analysis
Sequencing libraries were prepared each from four pooled independent
PolII-S5p ChIP samples from Patski cells or from an Xistmutant F1 brain using
the Illumina seq sample prep kit. Genomic DNA from the same batch of nuclei
from F1 brain was used for control library preparation. These libraries were
sequenced on Illumina Genome Analyzers, yielding 36 bp single-end reads
for ChIP-seq of Patski cells and 100 bp single-end reads for ChIP-seq and
gDNA-seq of F1 brain.
A pseudo-spretus genome was assembled by replacing available SNPs
between C57BL/6J and M. spretus (Sanger Center) into the BL6 reference
genome. Reads were aligned to the BL6 reference sequence (mm 9, UCSC)
(Waterston et al., 2002) and to the pseudo-spretus genome separately using
BWA (Burrows-Wheeler Aligner) (Li and Durbin, 2009). Only high-quality
uniquely-mapped reads were assigned to each haploid genome (see Supple-
mental Experimental Procedures). The SNP-associated read counts were
used to assess average allelic enrichment at expressed genes (R1RPKM).
PolII-S5p peak regions were selected using uniquely mapped reads by both
CisGenome (FDR = 1 3 105 as the cutoff) and Model-based Analysis of
ChIP-Seq (p = 1 3 105). We compared 10,325 autosomal and 326 X-linked
genes containing significant PolII-S5p peaks within a 2 kb region of the TSS.
Normalization of metagene ChIP-seq results was done using genomic
gDNA-seq data (see Supplemental Experimental Procedures).
Classification of Ancestral and Acquired Genes
Mouse ancestral X-linked genes were identified as those corresponding
to human X-linked genes that have orthologs on chicken chromosomes 1
and 4 based on a previous study (Bellott et al., 2010). The rest of mouse
X-linked genes were grouped as acquired. A set of mouse autosomal genes
corresponding to human genes on chromosomes 5 and 9, which match to
orthologs on chicken chromosome Z, were grouped as control mouse ances-
tral genes.
Expression Array and qRT-PCR Analyses
Affymetrix 430 2.0 and 1.0 ST Gene mouse arrays were used for expression
analyses in undifferentiated PGK12.1 ES cells and in MOF RNAi- and control
RNAi-treated ES cells (see Supplemental Experimental Procedures). X:A
expression ratios were calculated from the mean expression values of
X-linked and autosomal genes. For analysis of individual genes, expression
was normalized to the mean autosomal expression value of the array. We
grouped 21,253 autosomal and 908 X-linked genes into four expression cate-
gories (‘‘silent,’’ ‘‘low,’’ medium,’’ and ‘‘high’’), each containing 5,313 auto-
somal and 227 X-linked genes. These four categories were also applied to
classify 626 X-linked and 15,944 autosomal genes for metagene analyses
and calculations of binding changes. Two-tail Student’s t tests were used
to test the significance of expression changes of individual genes. One-way
ANOVA was used to test whether X-linked expression fold changes differed
between the four expression categories and from autosomal gene expression
changes. Quantitative RT-PCR was performed using a SYBR green master
mix (Roche) after reverse transcription of 1mg of total RNA. Detailed RT-
PCR protocols and primer information are described in Supplemental Exper-
imental Procedures.
RNAi Knockdown
A mixture of three Stealth Select siRNA duplexes (Invitrogen) was selected to
target different parts of the Mof mRNA. One Silencer Select siRNA duplex
(Invitrogen) was selected to target Msl1 mRNA and a mixture of two Silencer
Select siRNA duplexes to target Nsl1 (1700081L11Rik) mRNA. RNAi knock-
down was performed using gene-specific siRNAs and negative control66 Developmental Cell 25, 55–68, April 15, 2013 ª2013 Elsevier Inc.siRNAs with Invitrogen Lipofectamine RNAiMax (see Supplemental Experi-
mental Procedures).
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